Emerging sleep science venture DUSQ has closed a ₹24 crore seed funding round led by Fireside Ventures.
The round also saw participation from Antler India, Climber Capital, Startup Sherpas, Vaishav Investments, along with prominent angel investors including Avnish Anand (Founder, CaratLane) and Shivam Puri.
The company will channel the fresh capital into advancing its proprietary sleep regulation ecosystem, hiring across neuroscience and hardware engineering, accelerating intellectual property creation, upgrading its in-house sleep laboratories, and laying the groundwork for an expansion into the United States.
Established in 2023 by Dr. Siddhant Bhargava, Shalmali Kadu, and Mitansh Khurana, DUSQ operates at the intersection of neuroscience and applied hardware. Over a two-year research cycle, the founding team examined more than 50 million physiological data points to construct a biological regulation framework aimed at improving human recovery.
Unlike mainstream consumer sleep brands that center around analytics dashboards and sleep scores, DUSQ is building what it describes as a regulation-driven intervention platform. The company’s approach is based on the premise that persistent sleep disruption is rooted in brain–body misalignment, requiring active modulation of biological systems rather than passive monitoring.
Over the last year, the startup has conducted controlled studies within its proprietary sleep lab, focusing on autonomic nervous system pathways linked to recovery. Early trial outcomes, according to the company, indicate measurable improvements in sustained recovery cycles and the stabilization of uninterrupted sleep phases.
Previously operating under the name InnerGize, DUSQ positions itself as a deep-science health-tech company developing “infrastructure for recovery.” With the newly raised funds, it aims to scale its platform globally while reinforcing its scientific and hardware capabilities.
